EL DORADO HILLS, Calif., June 8, 2005 /PRNewswire-FirstCall via COMTEX/ -- NutraCea announced today that they have been issued a new patent, U.S. Patent Number 6,902,739, from the United States Patent and Trademark Office entitled, Methods for Treating Joint Inflammation, Pain and Loss of Mobility.
The patent contains 14 claims, which include a method for treating lameness, pain and loss of mobility in humans and mammals and a method for inhibiting prostaglandin synthetase activity, which is also known as COX-2 inhibition.
According to the Company, the new patent supports NutraCea's strategy of aggressive expansion of its intellectual property portfolio with proprietary technology based solutions that offer unique partnership and licensing opportunities across several multi-billion dollar segments for food, pharmaceutical and specialty healthcare companies.
"As Chairman of NutraCea's Medical Advisory Board, we're really pleased to have this patent issued, especially at a time when safe choices for treatment of arthritic pain and inflammation are being challenged with the recall of several pharmaceutical drugs," said Dr. Eliot Drell.
"Additionally, this patent is not limited in its application for humans but is extended to include all equine and other mammals as well. We feel it will be a positive step and add additional impetus for our existing product supply relationship with our equine provider; W.F. Young Company is a 113- year-old family-owned company, a leading developer and marketer of health, beauty and grooming products for the equine industry and external analgesics for the human healthcare market sold under the brand name of Absorbine Junior," commented McPeak.
NutraCea is a leader in stabilized rice bran nutrient research and dietary supplement development. The Company has developed intellectual property to create a range of proprietary product formulations, delivery systems and whole food nutrition products. NutraCea's proprietary technology enables the creation of food and nutrition products from rice bran, normally a waste by-product of standard rice processing. In addition to its whole foods products, NutraCea develops families of health-promoting "nutraceuticals," and all-natural "cosmeceutical" beauty aids. More information can be found in the company's filings with the SEC. and you can visit the NutraCea web site http://www.NutraCea.com.
This release contains statements that are forward looking. These statements are made based upon current expectations that are subject to risk and uncertainty. The Company does not undertake to update forward-looking statements in this news release to reflect actual results, changes in assumptions or changes in other factors affecting such forward-looking information. Assumptions and other information that could cause results to differ from those set forth in the forward-looking information can be found in the Company's filings with the Securities and Exchange Commission, including the company's most recent periodic report.